6Mendall MA, Goggin PM, Molineaux N, et al. Relation of Helicobacter pylori infection and coronary heart disease[J]. Br Heart J, 1994,71(5) :437-439. 被引量：1
7[1]Mendall MA, Goggin PM, Mobineaux N, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J, 1994;71:437～439 被引量：1
8[2]Frishman WH, Ismail AA, Role of infection in atherosclerosis and coronary artery disease: a new therapeutic target? Cardiol Rev, 2002,Jul-Aug; 10(4) : 199～210 被引量：1
9[3]Singh RK, McMahon AD, Patel H, et al. Prospective analysis of the association of infection with CagA bearing strains of Helicobacter pylori and coronary heart disease. Heart, 2002,Jul:88(1) :43～46 被引量：1
10[4]De Backer J, Mak R, De Bacquer D, et al. Parameters of inflammation and infection in a community based case-control study ofcoronary heart disease. Atherosclerosis, 2002, Feb : 160 (2) : 457～463 被引量：1
7Tsiodras S,Mantzoros C,Hammer S. Effccts of protease inhibitors on hyperglycemia,hyperipidemia,and lipodystrophy:a 5-year cohort study[J].Archives of Internal Medicine,2000.2050-2056. 被引量：1
8Kurug(o)l Z,Ulger Z,Berk O. Acquired partial lipodystrophy associated with varicella[J].Turkish Journal of Pediatrics,2009,(06):617-620. 被引量：1
9Misra A,Peethambaram A,Garg A. Clinical features and metabolic and autoimmune derangements in acquired partial lipodystmphy:report of 35 cases and review of the literature[J].Medicine(Baltimore),2004,(01):18-34. 被引量：1
10Lichtenstein KA. Redefining lipodystrophy syndrome:risks and impact on clinical decision making[J].J Acquit Immune Defic Syndrn,2005,(04):395-400.doi:10.1097/01.qai.0000167478.28051.3a. 被引量：1
